| Also known as |
Isoptin, Calan, Verelan |
| Blood pressure |
Lowers blood pressure |
| Chemical name |
Verapamil hydrochloride |
| Dosage (medical) |
80-120 mg orally three times a day or 180-240 mg in extended-release forms once daily for hypertension or angina |
| Dosage (sports) |
Not applicable, as it is not typically used for performance enhancement in sports |
| Effects |
Lowering of blood pressure, reduced angina, control of certain types of arrhythmias |
| Formula |
C27H38N2O4В·HCl |
| Half-life |
2.8 to 7.4 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Not specific, but monitoring of liver and kidney function may be required |
| Main action |
Reduces the entry of calcium into cardiac and smooth muscle cells, leading to vasodilation and decreased heart rate |
| Side effects |
Dizziness, headache, constipation, nausea, hypotension, bradycardia, and potential heart failure exacerbation |
| Storage conditions |
Store at room temperature, protect from light and moisture |
| Strength |
40 mg |
| Substance class |
Calcium channel blocker |
| Trade name |
Calan, Isoptin, Verelan |
| Use in sports |
Not commonly used in sports |
| Water Retention |
Minimal |
| Manufacturer |
Abbott Healthcare Pvt. Ltd. |
